Characteristics of neutralizing antibody titers of the SARS-CoV-2 vaccine in maintenance hemodialysis patients
Clinical Nephrology · 2024
DOI: 10.5414/cn111179 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Nephrology, 2024. Verfasst von Yoshifumi Amari und 7 weiteren Autor:innen. Hauptthemen laut MEDLINE: Renal Dialysis, COVID-19 Vaccines, COVID-19, Antibodies, Viral.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Amari, Y., Morimoto, S., Teranishi, T., Motoike, Y., Yurugi, T., Oyama, Y., Nakajima, F., & Kobayashi, H. (2024). Characteristics of neutralizing antibody titers of the SARS-CoV-2 vaccine in maintenance hemodialysis patients. Clinical Nephrology. https://doi.org/10.5414/cn111179
Vancouver
Amari Y, Morimoto S, Teranishi T, Motoike Y, Yurugi T, Oyama Y, et al. Characteristics of neutralizing antibody titers of the SARS-CoV-2 vaccine in maintenance hemodialysis patients. Clinical Nephrology. 2024. doi:10.5414/cn111179
BibTeX
@article{Amari2024,
author = {Amari, Yoshifumi and Morimoto, Satoshi and Teranishi, Takashi and Motoike, Yu and Yurugi, Takatomi and Oyama, Yasuo and Nakajima, Fumitaka and Kobayashi, Hitoshi},
title = {Characteristics of neutralizing antibody titers of the SARS-CoV-2 vaccine in maintenance hemodialysis patients},
journal = {Clinical Nephrology},
year = {2024},
doi = {10.5414/cn111179}
}
EUVIMED